http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106727511-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4045 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-08 |
| filingDate | 2016-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106727511-B |
| titleOfInvention | Epiphysin treats the purposes in the drug for loosening Periprosthetic chronic inflammation and destruction of bone in preparation |
| abstract | The present invention provides epiphysins to treat the purposes in the drug for loosening Periprosthetic chronic inflammation and destruction of bone in preparation.The chemical structural formula of the epiphysin is as follows: , the drug includes the above compound and pharmaceutically acceptable carrier of pharmaceutical effective dose.The present invention has excavated the new prospect in medicine of epiphysin, a new medicinal applications are opened up, it is curative for effect to prosthetic loosening, purposes with prosthetic loosening caused by efficient prevention and treatment wear particle, the expression of inflammatory factor can be significantly reduced simultaneously, mitigates inflammatory reaction caused by wear particle, inhibit osteoclast cell activation, promote bone to dissolve local new bone formation, mitigates destruction of bone caused by wear particle. |
| priorityDate | 2016-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 195.